Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by TB Alternative Assets Ltd.

TB Alternative Assets Ltd. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,574 shares of the medical equipment provider’s stock after selling 146 shares during the quarter. TB Alternative Assets Ltd.’s holdings in Intuitive Surgical were worth $1,344,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical in the third quarter worth about $558,807,000. International Assets Investment Management LLC grew its holdings in Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, State Street Corp grew its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.5 %

Shares of NASDAQ ISRG opened at $592.64 on Tuesday. The stock has a market cap of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 5.04 and a beta of 1.39. The stock has a 50 day moving average of $540.66 and a two-hundred day moving average of $499.64. Intuitive Surgical, Inc. has a twelve month low of $362.14 and a twelve month high of $597.68.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 1,012 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $514.00, for a total value of $520,168.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,830,084. This trade represents a 15.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,509 shares of company stock worth $22,602,212 in the last 90 days. 0.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently commented on ISRG. Truist Financial lifted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Raymond James boosted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.